与动脉硬性进展相关的代谢功能障碍相关的脂肪肝病状况的过渡模式:健康检查队列研究
Lei Liu1, Changfa Wang2, Shuwen Deng1
1Health Management Center, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, China.
Scientific reports
|June 15, 2023
概括
持续的与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 显著加快了动脉硬度的进展. 对于持久性MAFLD患者来说,控制血糖和甘油三很重要,以减轻这种风险.
科学领域:
- 心血管健康 心血管健康
- 代谢障碍 代谢障碍 代谢障碍
- 肝脏疾病 肝脏疾病
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 是与代谢障碍相关的日益关注的问题.
- 对MAFLD状态的动态变化及其对动脉硬性进展的影响尚不清楚.
研究的目的:
- 研究MAFLD的动态转变与动脉硬的进展之间的关联.
- 确定心脏代谢风险因素在MAFLD和动脉硬之间关系中的作用.
主要方法:
- 一项对8807名中国健康检查参与者的队列研究,随访时间中位数为50.2个月.
- 根据MAFLD状态,参与者被分为四组:没有,持久,发达和退行.
- 动脉硬度的进展是通过每年臂脉冲波速度 (ba-PWV) 的增加和发生率来衡量的.
主要成果:
- 与非MAFLD相比,持久性MAFLD的ba-PWV年增幅最高 (6.75厘米/秒/年),发达 (6.35厘米/秒/年) 和回归 (1.27厘米/秒/年) 组.
- 持久性MAFLD与动脉硬发生率的风险增加1.31倍有关.
- 快食葡萄糖和甘油三的动态增加是持续性MAFLD患者动脉硬发生率的关键驱动因素.
结论:
- 持久性MAFLD与加速的动脉硬性发展显著相关.
- 在持久性MAFLD中血糖和甘油三水平升高可能会导致动脉硬的发生.
相关概念视频
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
Inflammation
54.0K
Overview
54.0K
Peripheral Artery Disease I: Introduction
11
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
11
Overview of Fatty Acid Metabolism
30.8K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.8K
Coronary Artery Disease II: Pathophysiology
15
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15


